ロード中...
Defining the susceptibility of colorectal cancers to BH3-mimetic compounds
Novel targets are required to improve the outcomes for patients with colorectal cancers. In this regard, the selective inhibitor of the pro-survival protein BCL2, venetoclax, has proven highly effective in several hematological malignancies. In addition to BCL2, potent and highly selective small mol...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7483443/ https://ncbi.nlm.nih.gov/pubmed/32913182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-02815-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|